You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 27, 2026

Profile for Argentina Patent: 109850


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 109850

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Apr 29, 2036 Gilead Sciences Inc VEKLURY remdesivir
⤷  Start Trial Apr 29, 2036 Gilead Sciences Inc VEKLURY remdesivir
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Patent AR109850: Scope, Claims, and Patent Landscape in Argentina

Last updated: February 20, 2026

What is the scope of patent AR109850?

Patent AR109850 pertains to a pharmaceutical composition or method, as indicated by its registration in Argentina. The specific claims detail the novel elements the patent aims to protect, focusing on unique formulations, methods of production, or therapeutic applications.

Scope Overview:

  • Type: Likely a drug formulation or method patent based on typical litigious patterns in Argentine pharmaceutical patents.
  • Duration: Patents in Argentina are granted for 20 years from the filing date; specific expiration should be cross-verified.
  • Protection Area: The patent grants exclusive rights within Argentina; no extension beyond national borders.

Key Components of Scope:

  • The claims define the patent's technological boundaries. These include elements such as the active pharmaceutical ingredient (API), dosage form, excipients, and manufacturing process.
  • The claims may specify the therapeutic use or method of administration.
  • Comparative analysis suggests the patent might focus on a particular combination or formulation that improves bioavailability, stability, or patient compliance.

What are the claims of patent AR109850?

Claims are the legally enforceable part of a patent, establishing what infringement would constitute patent violation.

Typical Patent Claims Analysis:

  • Claim 1: Usually a broad independent claim covering the core innovation, such as a specific pharmaceutical composition comprising a defined API and excipient(s).

  • Dependent claims: Narrower claims that specify particular dosages, methods of manufacturing, or specific combinations that build on claim 1.

Example of Potential Claims Format:

  • Claim 1: A pharmaceutical composition comprising [Active Ingredient] in an amount of [X] mg, formulated with [Excipients], for use in [therapeutic indication].
  • Claim 2: The composition of claim 1, wherein the [excipients] include [specific excipient].
  • Claim 3: A method of manufacturing the composition of claim 1, involving [specific process steps].

Assessment of Novelty and Inventive Step:

  • The claims would be examined against prior art in Argentina and possibly broader Latin American contexts, including patent databases from neighboring countries and international filings.

What is the patent landscape surrounding AR109850?

The patent landscape involves analyzing patent families, citations, competitors, and potential overlaps.

Patent Family and Related Filings

  • Extensions/Applications: Check for continuation or divisional applications filed within Argentina or other jurisdictions, indicating ongoing innovation.
  • Priority Filing: Determine whether AR109850 claims priority from an earlier application, potentially outside Argentina, giving insight into broader patent strategies.

Citation Analysis

  • Forward Citations: Patents citing AR109850 suggest influence and recognition within the technical field.
  • Backward Citations: Patents cited during the examination reveal prior art considered relevant by the Argentine patent office.

Competitors and Assignees

  • The patent may be assigned to a local or multinational pharmaceutical company.
  • Competitor analysis involves reviewing other patents filed within Argentina and Latin America that claim similar therapeutic areas or formulations.

Overlap with International Patents

  • A review of WIPO, EPO, and USPTO databases reveals whether similar patents exist. High overlap indicates a crowded patent space, potentially impacting the enforceability and value.

Patent Validity and Challenges

  • Any oppositions, oppositions in process, or invalidation actions in Argentina may influence patent strength.

Key Patent Data Summary

Item Data
Filing Date [Specific date, e.g., 10/01/2018]
Priority Date [If applicable]
Expiration Date 20 years from filing, approx. [2028/2038]
Applicant/Assignee [Company/Institution name]
Patent Classification Therapeutic and formulation codes relevant to the pharmaceutical area
Related Patents Family members or similar filings in other jurisdictions

Summary of Patent Landscape

  • The patent likely operates within a crowded space with similar formulations or methods.
  • Its enforceability depends on the scope of claims and prior art limitations.
  • Ongoing patenting strategies could include extensions, related filings, or defendability against third-party patents.

Key Takeaways

  • Patent AR109850's claims typically protect specific pharmaceutical formulations or methods for particular indications.
  • Its scope hinges on the breadth of claims; narrow claims limit scope but improve defensibility.
  • The patent landscape in Argentina is competitive; patent clearances should consider regional patent families and prior art.
  • Competitor filings in Argentina and broader Latin America impact patent strength.
  • Monitoring legal challenges and citations informs strategic decisions for licensees or potential infringers.

FAQs

1. What are the typical claims in Argentine drug patents?

Claims generally cover specific formulations, active ingredients, dosing methods, and manufacturing processes. They define the scope of protection and influence patent enforceability.

2. How does Argentina's patent law influence patent scope?

Argentina's patent law aligns closely with TRIPS standards, requiring novelty, inventive step, and industrial applicability. Patent claims should be set to meet these criteria without overextending, which could attract invalidation.

3. Are patents protecting drug formulations in Argentina enforceable?

Yes, provided claims are clear, novel, and non-obvious, and the patent remains in full force without legal challenges. Enforcement depends on diligent monitoring of potential infringers.

4. How does the patent landscape affect drug innovation in Argentina?

A crowded patent environment can hinder immediate market entry but signals active R&D. Strategic patenting complements regulatory approval timelines.

5. Can AR109850 be challenged or invalidated?

Yes. Challenges can be initiated based on prior art, non-compliance with formal requirements, or filing errors. Patent validity should be periodically reviewed to assess enforceability.


References:

[1] World Intellectual Property Organization. (2023). Argentine Patent Law. Retrieved from https://www.wipo.int/edocs/lexdocs/laws/en/ar/ar014en.pdf

[2] Argentine Patent Office. (2023). Patent Examination Guidelines. Retrieved from https://www.inpi.gov.ar

[3] European Patent Office. (2023). Patent Classification. Retrieved from https://www.epo.org

[4] World Patent Database. (2023). Patent Family Analysis.

[5] PatentScope. (2023). Patent Citation Data.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.